We investigated the combined effects of estrogen deficiency and diabetes on
bone mineral density (BMD) and bone metabolism in rats. Ten-week-old, fema
le rats were randomly divided into four groups: controls (C), an ovariectom
ized group (O), a streptozotocin-induced diabetic group (S), and a combined
ovariectomy and streptozotocin-induced diabetic group (OS). The BMD of the
lumbar spine and the femur were measured before grouping and at 23 weeks o
ld. At the end of the experiment, blood samples were obtained via cardiac p
uncture, and bone gla protein (BGP), tartrate-resistant acid phosphatase (T
RAP) and 1,25-dihydroxyvitamin D levels were measured. The rats in the C, O
, S, and OS groups, in that order, had higher levels of BMD of the lumbar s
pine and femur at 23 weeks of age. The BGP levels in the S and OS groups we
re significantly lower than in C and O groups. Significantly higher 1,25-di
hydroxyvitamin D was observed in the O group compared with the C, S and OS
groups. No differences were obtained in TRAP among four groups. Our data su
ggest that the combined effects of estrogen deficiency and diabetes on BMD
are not synergistic or counteractive but additive. (C) 2000 Elsevier Scienc
e Ireland Ltd. All rights reserved.